Risk for Stroke, TIA Increased in Adults With Sickle Cell Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 25, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Sept. 25, 2024 -- Adults with sickle cell disease (SCD) have an increased risk for stroke and transient ischemic attack (TIA), according to a study published online Sept. 20 in Blood.

Olubusola Oluwole, M.D., from the University of Pittsburgh, and colleagues determined the cumulative incidence and rates for primary and recurrent strokes and TIAs in people with SCD before and after the STOP trial of 1998, which established chronic transfusions as the standard of care for children with SCD at high risk for stroke. The cohort included 7,636 patients with SCD.

The researchers found that the cumulative incidence was 2.1 and 13.5 percent for first ischemic stroke by age 20 years and by age 60 years, respectively. The corresponding cumulative incidence for first intracranial hemorrhage was 0.5 and 6.8 percent, respectively. Compared with the preceding decade, in 2010 to 2019, there was an increase in ischemic stroke rates in children (younger than 18 years: 234.9 versus 165.1 per 100,000 person-years) and adults (31 to 50 years: 431.1 versus 303.2 per 100,000 person-years). Compared with the previous decade, in 2010 to 2019 the rates of intracranial hemorrhage increased in those aged 18 to 30 years and TIA increased in children younger than 18 years. Older age, hypertension, and hyperlipidemia were risk factors for stroke and TIA.

"As people with SCD live longer, there remains an unmet need to develop guidelines for primary and secondary stroke prevention in adults at highest risk for neurological debility from adverse cerebrovascular events," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords